CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 36  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.1495
LYS 10.1495
GLU 20.0646
LEU 30.0305
ARG 40.0201
CYS 50.0159
GLN 60.0174
CYS 70.0151
ILE 80.0249
LYS 90.0300
THR 100.0219
TYR 110.0143
SER 120.0126
LYS 130.0117
PRO 140.0062
PHE 150.0056
HIS 160.0131
PRO 170.0089
LYS 180.0050
PHE 190.0089
ILE 200.0075
LYS 210.0118
GLU 220.0121
LEU 230.0084
ARG 240.0133
VAL 250.0095
ILE 260.0158
GLU 270.0130
SER 280.0223
GLY 290.0482
PRO 300.0388
HIS 310.0236
CYS 320.0439
ALA 330.0706
ASN 340.0352
THR 350.0205
GLU 360.0058
ILE 370.0087
ILE 380.0124
VAL 390.0076
LYS 400.0108
LEU 410.0135
SER 420.0135
ASP 430.0338
GLY 440.0185
ARG 450.0139
GLU 460.0090
LEU 470.0047
CYS 480.0123
LEU 490.0120
ASP 500.0175
PRO 510.0161
LYS 520.0187
GLU 530.0113
ASN 540.0263
TRP 550.0075
VAL 560.0116
GLN 570.0194
ARG 580.0085
VAL 590.0048
VAL 600.0055
GLU 610.0079
LYS 620.0076
PHE 630.0070
LEU 640.0079
LYS 650.0078
ARG 660.0113
ALA 670.0112
GLU 680.0038
ASN 690.0174

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.